PFIZER DUMPS ITS PROPOSAL TO SPLIT INTO TWO

Pfizer said Monday that it had decided against splitting into two companies, a possibility the pharmaceutical giant had considered after the Obama administration crushed its tax inversion hopes. The New Yorkbased drugmaker had been weighing a plan to split into two companies — one devoted to its established products and one focused on new, advanced treatments. Pfizer shares fell 1.8% to close at $33.64.